Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI
JACC: Cardiovascular Interventions · 2023-04 · 16 (7) · 771-779
DOI: 10.1016/j.jcin.2023.01.380 ↗Kurz gefasst
Klinische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2023-04. Verfasst von Ioannis Merinopoulos und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Norfolk and Norwich University Hospital, Norwich, United Kingdom; Norwich Medical School, University of East Anglia, Norwic…. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Drug-Eluting Stents, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Department of Health.
Abstract (Originalsprache)
BACKGROUND: Primary percutaneous coronary intervention (pPCI) with drug-eluting stents (DES) has emerged as the standard of care, but stent-related events have persisted. Drug-coated balloon (DCB)-only angioplasty is an emerging technology, although it is not fully evaluated compared with DES in the context of pPCI. OBJECTIVES: The aim of this study was to investigate the safety of DCB-only angioplasty compared with second-generation DES in pPCI. METHODS: All-cause mortality and net adverse cardiac events (cardiovascular mortality, acute coronary syndrome, ischemic stroke or transient ischemic attack, major bleeding, and unplanned target lesion revascularization [TLR]) were compared among all patients treated with DCBs only or with second-generation DES only for first presentation of ST-segment elevation myocardial infarction (STEMI) due to de novo disease between January 1, 2016, and November 15, 2019. Patients treated with both DCBs and DES were excluded. Data were analyzed using Cox regression models, Kaplan-Meier estimator plots and propensity score matching. RESULTS: Among 1,139 patients with STEMI due to de novo disease, 452 were treated with DCBs and 687 with DES. After a median follow-up period of >3 years, all-cause mortality was 49 of 452 and 62 of 687 in the DCB and DES groups, respectively (P = 0.18). On multivariable Cox regression analysis, there was no difference in mortality between DCBs and DES in the full and propensity score-matched cohorts. Age, frailty risk, history of heart failure, and family history of ischemic heart disease remained significant independent predictors of mortality. There was no difference in any of the secondary endpoints, including unplanned TLR. CONCLUSIONS: DCB-only angioplasty appears safe compared with DES for STEMI in terms of all-cause mortality and all net adverse cardiac events, including unplanned TLR. DCB may be an efficacious and safe alternative to DES in selected patient groups. (Drug Coated Balloon Only vs Drug Eluting Stent Angioplasty; NCT04482972).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Norfolk and Norwich University Hospital, Norwich, United Kingdom; Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
- Department of Cardiology, Norfolk and Norwich University Hospital, Norwich, United Kingdom.
- Keele Cardiovascular Research Group, Keele University, Keele, United Kingdom; Institute of Health Informatics, University College London, London, United Kingdom.
- Department of Mathematics, University of Newcastle, Newcastle, United Kingdom.
- Keele Cardiovascular Research Group, Keele University, Keele, United Kingdom.
- Department of Cardiology, Norfolk and Norwich University Hospital, Norwich, United Kingdom; Norwich Medical School, University of East Anglia, Norwich, United Kingdom. Electronic address: v.vassiliou@uea.ac.uk.
Förderung
- Department of Health
Zitieren
APA
Merinopoulos, I., Gunawardena, T., Corballis, N., Bhalraam, U., Reinhold, J., Wickramarachchi, U., Maart, C., Gilbert, T., Richardson, P., Sulfi, S., Sarev, T., Sawh, C., Wistow, T., Ryding, A., Mohamed, M. O., Perperoglou, A., Mamas, M. A., Vassiliou, V. S., & Eccleshall, S. C. (2023). Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI. JACC: Cardiovascular Interventions, 16(7), 771-779. https://doi.org/10.1016/j.jcin.2023.01.380
Vancouver
Merinopoulos I, Gunawardena T, Corballis N, Bhalraam U, Reinhold J, Wickramarachchi U, et al. Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI. JACC: Cardiovascular Interventions. 2023;16(7):771-779. doi:10.1016/j.jcin.2023.01.380
BibTeX
@article{Merinopoulos2023,
author = {Merinopoulos, Ioannis and Gunawardena, Tharusha and Corballis, Natasha and Bhalraam, U and Reinhold, Johannes and Wickramarachchi, Upul and Maart, Clint and Gilbert, Tim and Richardson, Paul and Sulfi, Sreekumar and Sarev, Toomas and Sawh, Chris and Wistow, Trevor and Ryding, Alisdair and Mohamed, Mohamed O and Perperoglou, Aris and Mamas, Mamas A and Vassiliou, Vassilios S and Eccleshall, Simon C},
title = {Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI},
journal = {JACC: Cardiovascular Interventions},
year = {2023},
volume = {16},
number = {7},
pages = {771--779},
doi = {10.1016/j.jcin.2023.01.380}
}
EUVIMED